Further than its pain-relieving outcomes, conolidine has demonstrated a positive security margin in preclinical toxicology assessments. Unlike opioids, which often lead to respiratory depression at better doses, conolidine hasn't developed indications of important respiratory suppression. Also, behavioral assessments in murine products propose an absence of drug-in search of behaviors, https://hannesl715fdb5.wikiexpression.com/user